D1000VFARMA (DMVF3) Main Indicators
Basic Data - DMVF3
Company | D1000VFARMA |
Corporate Name | D1000 VAREJO FARMA PARTICIPAÇÕES S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | A Companhia tem por objeto a participação. como sócia ou acionista. em outras sociedades do varejo farmacêutico. nacionais ou estrangeiras. |
Share | DMVF3 |
Quote Date | 11/08/2024 |
Share Type | ON |
Last Closing | R$ 7.00 |
Quotation Factor | 1 Share |
Financial Volume | R$ 695.20 thousand |
Last Statement | ITR - 09/30/2024 |
Sector | Saúde |
Subsector | Comércio e Distribuição |
Segment | Medicamentos e Outros Produtos |
Participation Indexes | IGC, IGNM, ITAG |
Updated 11/09/2024 |
Relative Prices - DMVF3
Price/Earnings | 11.21 |
Price/SBV | 0.40 |
Price/Net Sales | 0.18 |
Price/CFO | 2.19 |
Price/FCF | 3.63 |
Price/Total Assets | 0.21 |
Price/EBIT | 5.15 |
Price/Working Capital | 5.58 |
Price/NCAV | -0.46 |
EV/EBIT | 4.90 |
EV/EBITDA | 1.85 |
EV/Net Sales | 0.17 |
EV/CFO | 2.08 |
EV/FCF | 3.45 |
EV/Total Assets | 0.20 |
Company Market Cap | R$ 354.22 M |
Enterprise Value | R$ 336.58 M |
Current Financial Statement Date | 09/30/2024 |
Current Share Price | R$ 7.00 |
Share Price Date | 11/08/2024 |
Dividend Yield | 0.00% |
Updated 11/09/2024 |
Income Statement - DMVF3
Net Revenue | R$ 2.00 B |
Gross Result | R$ 632.34 M |
EBIT | R$ 68.73 M |
Depreciation and Amortization | - R$ 113.57 M |
EBITDA | R$ 182.30 M |
Net Profit | R$ 31.59 M |
Net Profit/Share | R$ 0.62 |
Updated 10/30/2024 |
Net Revenue | R$ 544.48 M |
Gross Result | R$ 171.41 M |
EBIT | R$ 20.85 M |
Depreciation and Amortization | - R$ 29.73 M |
EBITDA | R$ 50.59 M |
Net Profit | R$ 10.35 M |
Profit/Share | R$ 0.20 |
Updated 10/30/2024 |
Price and Volume Behavior - DMVF3
Lowest Price 52 weeks | R$ 4.48 |
Highest Price 52 weeks | R$ 8.38 |
Variation 2024 | 23.67% |
Variation 1 year | 56.25% |
Variation 2 years(total) | 50.21% |
Variation 2 years(yearly) | 22.53% |
Variation 3 years(total) | 16.67% |
Variation 3 years(yearly) | 5.27% |
Variation 4 years(total) | -35.06% |
Variation 4 years(yearly) | -10.21% |
Variation 5 years(total) | - |
Variation 5 years(yearly) | - |
Average Daily Volume (3 months) | R$ 624.45 thousand |
Updated 11/09/2024 |
Returns and Margins - DMVF3
Return on Initial Tangible Capital | 9.30% |
Return on Initial Invested Capital | 5.42% |
Pre-Tax Return on Initial Tangible Capital | 14.09% |
Pre-Tax Return on Initial Invested Capital | 8.22% |
Return on Initial Shareholder´s Equity | 3.67% |
Return on Initial Asset | 2.08% |
Gross Margin | 31.58% |
Net Margin | 1.58% |
EBIT Margin | 3.43% |
EBITDA Margin | 9.10% |
Initial Asset Turnover | 1.32 |
Financial Leverage | 1.93 |
Liabilities/Net Worth | 0.93 |
Net Debt/EBITDA | -0.10 |
Updated 10/30/2024 |
Balance Sheet - DMVF3
Cash and Cash Equivalents | R$ 39.21 M |
Total Assets | R$ 1.72 B |
Short-Term Debt | R$ 10.68 M |
Long-Term Debt | R$ 10.89 M |
Gross Debt | R$ 21.57 M |
Net Debt | - R$ 17.64 M |
Shareholder´s Equity | R$ 893.21 M |
Share Book Value | R$ 17.65 |
Common Shares | 50,603,000 |
Preferred Shares | 0 |
Total | 50,603,000 |
Common Shares in Treasury | 0 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 0 |
Common Shares (Except Treasury) | 50,603,000 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 50,603,000 |
Updated 10/30/2024 |
Cash Flow - DMVF3
Operating Cash Flow | R$ 161.56 M |
Cash Flow from Investments | - R$ 81.94 M |
Financing Cash Flow | - R$ 92.39 M |
Increase (Reduction) in Cash and Equivalents | - R$ 12.77 M |
Updated 10/30/2024 |
Operating Cash Flow | R$ 45.34 M |
Cash Flow from Investments | - R$ 26.62 M |
Financing Cash Flow | - R$ 28.16 M |
Increase (Reduction) in Cash and Equivalents | - R$ 9.43 M |
Updated 10/30/2024 |
Experimental - DMVF3
CAPEX 3 months | - R$ 19.70 M |
Free Cash Flow 3 months | R$ 25.65 M |
CAPEX 12 months | - R$ 63.99 M |
Free Cash Flow 12 months | R$ 97.57 M |
Updated 10/30/2024 |